Market Overview:
The global non-wearable blood glucose monitoring systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in blood glucose monitoring systems, and rising demand for home-based blood glucose monitoring systems. Based on type, the global non-wearable blood glucose monitoring systems market is segmented into blood glucose meters and testing strips. The testing strips segment is expected to account for a larger share of the market than the meter segment during the forecast period. This can be attributed to factors such as increasing demand for self-monitoring devices and growing awareness about diabetes among people across the globe. Based on application, hospitals are estimated to account for a larger share of the global non-wearable blood glucose monitoring systems market than clinics during 2018–2030 owing to an increase in number of hospital admissions due to diabetes mellitus (DM).
Product Definition:
Non-wearable blood glucose monitoring systems are devices that allow people with diabetes to monitor their blood sugar levels without having to prick their fingers. These systems consist of a small sensor that is inserted just below the skin, and a transmitter that sends data from the sensor to a receiver. The receiver can then be used to track blood sugar levels over time. Non-wearable blood glucose monitoring systems are important because they allow people with diabetes to monitor their blood sugar levels without having to prick their fingers, which can be painful and inconvenient.
Blood Glucose Meter:
Blood glucose meters have been in use for over two decades. The first FDA approved blood glucose meter was the Accu-Check by Abbott Laboratories in 1997. Since then, many new products have come onto the market and a large number of these are now available in the international market place. Some key players operating globally include Roche Diagnostics, Bayer Healthcare AG., LifeScan Inc., Nova Biomedical Inc., Ypsomed Holding AG and FreeStyle Navigator Inc among others.
Blood Glucose Testing Strips:
Blood glucose testing strips are used in non-wearable blood glucose monitoring systems. These products are available as pre-cut, ready to use test strips that can be easily applied on the skin. The major advantage of these products is that they eliminate the need for a continuous blood glucose monitor and allow users to carry out multiple tests at one time.
These testing strips help in measuring blood sugar levels.
Application Insights:
The others application segment includes home healthcare, clinics and hospitals, and other applications. The hospital segment dominated the global non-wearable blood glucose monitoring systems market in 2017 due to factors such as increasing prevalence of diabetes coupled with rising awareness about self-monitoring devices. Furthermore, an increase in the adoption of these devices by patients for better management of their disease is expected to boost growth over the forecast period.
The hospital segment accounted for a revenue share of 60.1% in 2017 owing to factors such as high usage rates among diabetic patients at hospitals or medical centers that offer 24X7 access to healthcare professionals through remote patient monitoring services using these products. These remote patient monitoring services help reduce medication errors and improve compliance with treatment procedures which further boosts its demand globally across various regions where it is legal and permitted by authorities to use this technology within healthcare facilities only (others).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high awareness levels coupled with relatively higher healthcare expenditure and adoption rate of advanced technologies in this region. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising incidences diabetes and obesity which are majorly caused by unhealthy lifestyle habits such as lack of physical activity, poor dietary habits, and excessive consumption of sugar-sweetened beverages. In addition, increasing government initiatives for creating awareness about non-wearable devices is also anticipated to propel regional market growth during the forecast period. For instance, Diabetes Australia has collaborated with Novo Nordisk A/S., GlaxoSmithKline plc., Sanofi SA., Novo Nordisk A/S., Merck KGaA Dohle GmbH & Co.; insulin products manufacturer Eli Lilly & Company; and insulin pen manufacturers BMS Health Products Inc.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for blood glucose monitoring systems in the coming years.
- Growing awareness about diabetes and its complications: There is a growing awareness among people about diabetes and its complications. This is likely to increase the demand for blood glucose monitoring systems in the near future.
- Technological advancements: The development of new technologies has led to the introduction of innovative blood glucose monitoring systems in the market, which are more accurate and user-friendly than traditional devices. This is likely to boost the growth of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-wearable Blood Glucose Monitoring Systems Market Research Report
By Type
Blood Glucose Meter, Blood Glucose Testing Strips
By Application
Hospitals, Clinics, Others
By Companies
Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical, Bionime Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Non-wearable Blood Glucose Monitoring Systems Market Report Segments:
The global Non-wearable Blood Glucose Monitoring Systems market is segmented on the basis of:
Types
Blood Glucose Meter, Blood Glucose Testing Strips
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Medtronic
- Roche
- Bayer AG
- B. Braun
- Nipro Diagnostics
- Life Scan Inc.(J&J)
- Arkray Devices
- Nova Biomedical
- Bionime Corporation
Highlights of The Non-wearable Blood Glucose Monitoring Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Glucose Meter
- Blood Glucose Testing Strips
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-wearable Blood Glucose Monitoring Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-wearable blood glucose monitoring systems are a type of continuous glucose monitor that does not require any kind of adhesive or band to be worn on the body. These monitors use a small sensor that is inserted under the skin and sends readings wirelessly to a receiver device.
Some of the major companies in the non-wearable blood glucose monitoring systems market are Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical, Bionime Corporation.
The non-wearable blood glucose monitoring systems market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-wearable Blood Glucose Monitoring Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-wearable Blood Glucose Monitoring Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-wearable Blood Glucose Monitoring Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-wearable Blood Glucose Monitoring Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-wearable Blood Glucose Monitoring Systems Market Size & Forecast, 2018-2028
4.5.1 Non-wearable Blood Glucose Monitoring Systems Market Size and Y-o-Y Growth
4.5.2 Non-wearable Blood Glucose Monitoring Systems Market Absolute $ Opportunity
Chapter 5 Global Non-wearable Blood Glucose Monitoring Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Type
5.2.1 Blood Glucose Meter
5.2.2 Blood Glucose Testing Strips
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Non-wearable Blood Glucose Monitoring Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-wearable Blood Glucose Monitoring Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Non-wearable Blood Glucose Monitoring Systems Analysis and Forecast
9.1 Introduction
9.2 North America Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Type
9.6.1 Blood Glucose Meter
9.6.2 Blood Glucose Testing Strips
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Non-wearable Blood Glucose Monitoring Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Type
10.6.1 Blood Glucose Meter
10.6.2 Blood Glucose Testing Strips
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Non-wearable Blood Glucose Monitoring Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Type
11.6.1 Blood Glucose Meter
11.6.2 Blood Glucose Testing Strips
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Non-wearable Blood Glucose Monitoring Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Type
12.6.1 Blood Glucose Meter
12.6.2 Blood Glucose Testing Strips
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Non-wearable Blood Glucose Monitoring Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Type
13.6.1 Blood Glucose Meter
13.6.2 Blood Glucose Testing Strips
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Non-wearable Blood Glucose Monitoring Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-wearable Blood Glucose Monitoring Systems Market: Competitive Dashboard
14.2 Global Non-wearable Blood Glucose Monitoring Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Medtronic
14.3.3 Roche
14.3.4 Bayer AG
14.3.5 B. Braun
14.3.6 Nipro Diagnostics
14.3.7 Life Scan Inc.(J&J)
14.3.8 Arkray Devices
14.3.9 Nova Biomedical
14.3.10 Bionime Corporation
